Document Detail

Differential expression of lumican and fatty acid binding protein-1: new insights into the histologic spectrum of nonalcoholic fatty liver disease.
MedLine Citation:
PMID:  19330863     Owner:  NLM     Status:  MEDLINE    
CONCLUSION: Histologically progressive NAFLD is associated with overexpression of lumican, an important mediator of fibrosis in nonhepatic tissues, whereas FABP-1 is paradoxically underexpressed in NASH, suggesting a new potential mechanism of lipotoxicity in NAFLD. Further studies are needed to determine the biologic basis of lumican and/or FABP-1 dysregulation in NAFLD.
Michael Charlton; Kimberly Viker; Anuradha Krishnan; Schuyler Sanderson; Bart Veldt; A J Kaalsbeek; Michael Kendrick; Geoffrey Thompson; Florencia Que; James Swain; Michael Sarr
Related Documents :
410833 - Ultrasonic backscatter from human liver tissue: its dependence on frequency and protein...
894363 - Influence of diet on in vitro and in vivo rates of fatty acid synthesis in coho salmon ...
16026003 - Identification of a na+-dependent cationic and neutral amino acid transporter, b(0,+), ...
Publication Detail:
Type:  Comparative Study; Journal Article; Research Support, N.I.H., Extramural    
Journal Detail:
Title:  Hepatology (Baltimore, Md.)     Volume:  49     ISSN:  1527-3350     ISO Abbreviation:  Hepatology     Publication Date:  2009 Apr 
Date Detail:
Created Date:  2009-04-06     Completed Date:  2009-05-08     Revised Date:  2014-09-14    
Medline Journal Info:
Nlm Unique ID:  8302946     Medline TA:  Hepatology     Country:  United States    
Other Details:
Languages:  eng     Pagination:  1375-84     Citation Subset:  IM    
Export Citation:
APA/MLA Format     Download EndNote     Download BibTex
MeSH Terms
Chondroitin Sulfate Proteoglycans / metabolism*
Fatty Acid-Binding Proteins / metabolism*
Fatty Liver / metabolism*,  pathology
Keratan Sulfate / metabolism*
Liver / metabolism*,  pathology
Middle Aged
Obesity / metabolism*
Polymerase Chain Reaction
RNA, Messenger / isolation & purification
Tandem Mass Spectrometry
Grant Support
R01 DK069757/DK/NIDDK NIH HHS; R01 DK069757-01/DK/NIDDK NIH HHS; R01 DK069757-01/DK/NIDDK NIH HHS; R01 DK069757-04/DK/NIDDK NIH HHS; RR00585/RR/NCRR NIH HHS
Reg. No./Substance:
0/Chondroitin Sulfate Proteoglycans; 0/FABP1 protein, human; 0/Fatty Acid-Binding Proteins; 0/RNA, Messenger; 0/lumican; 9056-36-4/Keratan Sulfate

From MEDLINE®/PubMed®, a database of the U.S. National Library of Medicine

Previous Document:  Multidetector Computed Tomography in Post-traumatic Ventricular Pseudoaneurysm.
Next Document:  Alzheimer's disease: from pathology to therapeutic approaches.